Schultze Special Purpose Drops a “Teaser” Ahead of Extension Vote
by Kristi Marvin on 2020-06-01 at 11:16am

We have another teaser….this morning, Schultze Special Purpose Acquisition Corp. (SAMA), announced ahead of their forthcoming deadline extension vote that they have signed a non-binding LOI with Clever Leaves, a multi-national cannabis operator.

Interestingly, this is not a teaser where the SPAC makes you guess who they’re buying.  Instead, SAMA is stating exactly who it is they’re negotiating with and have even provide quotes from Clever Leave’s CEO.  This deal sounds fully-baked and yet they still do not have signed a definitive agreement. Perhaps Clever Leaves is waiting to see the results of the extension vote and how much cash is left in trust before they commit to terms. However, without a signed definitive agreement, we can’t technically move SAMA into the “announced” column just yet.

Nevertheless, today’s press release did provide some information on the intended target.  Clever Leaves operates globally with operations and facilities in Colombia, Portugal, the United States, Canada and Germany, producing pharmaceutical grade cannabis. The Company currently cultivates in over 1.9 million square feet of greenhouses, making it one of the largest cannabis cultivation and extraction companies globally.  Clever Leaves is also in the process of becoming one of the few cannabis companies in the world, and the only cannabis company in Latin America, to be granted a European Union Good Manufacturing Practice (“EU GMP”) certification for extracts, subject to successful completion of the certification process.

We currently have seven cannabis-focused SPACs out searching for targets, but it appears SAMA, which initially intended to focus on restructured companies, beat them all to announcing a cannabis combination.  To-date, only MTech (now Akerna – KERN) has closed a cannabis combination.  Although, Akerna was only “cannabis-adjacent” since it provided compliance technology to the sector, i.e., it was not involved in production or distribution.  If SAMA does “definitively” announce and this looks like a good deal, this could be the shot in the arm the rest of the field needs to announce their own cannabis deals. A “contact high”, so to speak.

SAMA goes to a vote next Tuesday, June 9th, and it sounds like we can expect a full announcement and definitive agreement shortly thereafter.  We’ll have to wait and see.

 

Recent Posts
by Kristi Marvin on 2025-05-31 at 10:02am

Terms Tracker for the Week Ending May 30, 2025 Welcome to our weekly column where we discuss the findings from our IPO terms tracker based on the previous week’s pricings. May went out with a bang. Four more IPOs priced this week, bringing the monthly tally to 22 and the YTD total to 53. That...

by Nicholas Alan Clayton on 2025-05-30 at 2:55pm

June is set to be one of the quietest months in some time in terms of sponsors and de-SPAC’d companies coming free from their lock-ups, owing to the quieter periods for transactions closing that occurred six and 12 months ago. Up first will be company shareholders for East Asian media conglomerate TNL Mediagene (NASDAQ:TNMG) on...

by Nicholas Alan Clayton on 2025-05-30 at 12:37pm

Pioneer I (NASDAQ:PACHU) has filed for a $220 million SPAC to hunt for a healthcare target with a mix of industry veterans heading up its team. The new SPAC is the 12th new S-1 underwritten by Cantor Fitzgerald this year as left lead as it hopes to join the 10 SPACs that the underwriter has...

by Nicholas Alan Clayton on 2025-05-30 at 8:24am

At the SPAC of Dawn This week comes to an end with a flurry of SPAC votes including three special meetings called for shareholders to approve business combinations. Aetherium (OTC:GMFI) was also scheduled to seek shareholder approval for its extension proposal, but has punted this vote for two weeks to June 13. Two of today’s...

by Nicholas Alan Clayton on 2025-05-29 at 8:22am

At the SPAC of Dawn After multiple days of market rallies, traders are set to ingest a full plate of economic indicators today with jobless claims coming first, followed by a GDP growth revisions, home sales and a raft of Fed comments. GDP figures for the first quarter are broadly forecast to be revised downward...

logo

Copyright © 2025 SPACInsider, Inc. All Rights Reserved